bone graft substitute Articles
-
Programmed Drug Release of rhBMP-2 for Bone Healing
Summary: Non-union of bone fractures can cause pain and disabilities. Amongst certain fracture types, in specific age groups, the incidence of non-union is over 8% in the United States and over 3.6% of all fractures in the UK. Fracture non-unions have lifelong consequences and a debilitating impact in patients' life. Bone-grafts, allografts and xenograft are currently used to treat bone ...
-
Change in Number of Shares and Votes in Bonesupport Holding Ab (PUBL)
BONESUPPORT Holding AB (publ), an emerging leader in orthobiologics for the management of bone injuries, today announced a change in the number of shares and votes. During August, the number of shares and votes in BONESUPPORT Holding AB (publ) has increased with 10,000 due to the exercise of warrants. As of 31 August 2021, the number of shares in BONESUPPORT HOLDING AB (publ) amounts to ...
-
Study Results On Fortify Are Inconclusive
BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries, today announced inconclusive results for the company’s Investigational Device Exemption (IDE) study; FORTIFY. The primary safety endpoint for CERAMENT G was met. The FORTIFY study was initiated in 2017 with the purpose to evaluate the ability of CERAMENT G to improve the treatment outcomes for ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you